Hims & Hers (HIMS) CFO exercises options and sells 5,262 shares in planned trade

Filing Impact

(High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Hims & Hers Health, Inc.’s Chief Financial Officer, Oluyemi Okupe, reported an option exercise and share sale in Class A Common Stock on February 3, 2026.

He exercised 5,262 stock options at an exercise price of $5.01 per share, then sold 5,262 shares of Class A Common Stock at an average price of $26.4363 per share under a Rule 10b5-1 trading plan adopted on May 21, 2025. After these transactions, he directly owned 91,617 shares of Class A Common Stock and 144,051 stock options, and indirectly held 7,853 shares through the Oluyemi Okupe Separate Property Trust dated September 1, 2021.

Insider Trade Summary

Net Seller: 5,262 shares ($139,108)

Net Sell 4 txns

Insider Okupe Oluyemi

Role Chief Financial Officer

Sold 5,262 shs ($139K)

Type	Security	Shares	Price	Value
Exercise	Stock Option (right to buy)	5,262	$0.00	--
Exercise	Class A Common Stock	5,262	$5.01	$26K
Sale	Class A Common Stock	5,262	$26.4363	$139K
holding	Class A Common Stock	--	--	--

Holdings After Transaction: Stock Option (right to buy) — 144,051 shares (Direct); Class A Common Stock — 96,879 shares (Direct); Class A Common Stock — 7,853 shares (Indirect, Held by Oluyemi Okupe Separate Property Trust dtd 9-1-2021)

Footnotes (1)

The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $26.35-$26.56. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. The Reporting Person received stock options to purchase shares of Class A Common Stock. The stock options vest over a 4-year period, with 1/48 of the shares vesting when the Reporting Person completes each month of continuous service, beginning March 24, 2022.

Form 4 Insider Transactions: What Each Field Means →

02/04/2026 - 04:13 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Okupe Oluyemi

(Last)

(First)

(Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO

94123

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	02/03/2026		M⁽¹⁾		5,262	A	$5.01	96,879	D
Class A Common Stock	02/03/2026		S		5,262	D	$26.4363⁽²⁾	91,617	D
Class A Common Stock								7,853	I	Held by Oluyemi Okupe Separate Property Trust dtd 9-1-2021

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (right to buy)	$5.01	02/03/2026		M⁽¹⁾			5,262	⁽³⁾	02/23/2032	Class A Common Stock	5,262	$0	144,051	D

Explanation of Responses:

1. The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

2. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $26.35-$26.56. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

3. The Reporting Person received stock options to purchase shares of Class A Common Stock. The stock options vest over a 4-year period, with 1/48 of the shares vesting when the Reporting Person completes each month of continuous service, beginning March 24, 2022.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Oluyemi Okupe	02/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did HIMS CFO Oluyemi Okupe report on February 3, 2026?

Hims & Hers CFO Oluyemi Okupe reported exercising 5,262 stock options and selling 5,262 Class A Common shares on February 3, 2026. The exercise price was $5.01 per share and the sale price averaged $26.4363 per share, according to the Form 4 filing.

How many HIMS shares did the CFO sell and at what price?

The CFO sold 5,262 shares of Hims & Hers Class A Common Stock at an average price of $26.4363 per share. The filing notes this is a weighted average, with individual sale prices ranging from $26.35 to $26.56 across multiple trades.

Were the HIMS insider transactions under a Rule 10b5-1 trading plan?

Yes. The Form 4 states the stock option exercises and related sales were executed under a Rule 10b5-1 trading plan. This plan was adopted on May 21, 2025, providing a pre-arranged schedule for trades independent of subsequent non-public information.

How many HIMS shares does the CFO own after the reported transactions?

After the reported trades, the CFO directly owned 91,617 shares of Hims & Hers Class A Common Stock. He also indirectly held 7,853 additional shares through the Oluyemi Okupe Separate Property Trust dated September 1, 2021, as disclosed in the Form 4.

What HIMS stock options does the CFO hold following this Form 4 filing?

Following the option exercise, the CFO beneficially owned 144,051 stock options with a $5.01 exercise price. These options relate to Class A Common Stock and were originally granted to vest monthly over four years, beginning March 24, 2022, subject to continuous service.

How do the vesting terms of the HIMS CFO’s stock options work?

The CFO’s stock options vest over four years, with 1/48 of the shares vesting each month of continuous service. Vesting began on March 24, 2022. This structure provides gradual ownership of options tied to ongoing employment with Hims & Hers Health, Inc.